Generic Drug Manufacturer to Invest $31.3M in Fayetteville Plant

by Arkansas Business Staff  on Monday, Nov. 27, 2017 3:20 pm   2 min read

Dr. Peter Kohler (UAMS)

OurPharma of Fayetteville plans to invest $31.3 million in a Fayetteville facility that will develop lower-cost alternatives to generic drugs.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access stories older than 15 days.

Purchase Now

Already have archive access? Login to view this article.